Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Search content at Oregon Health & Science University
Home
Profiles
Research units
Core Facilities
Publications
Antiangiogenic agents in vitreoretinal disease
C. J. Flaxel
, H. Klassen
, Z. J. Gregor
Research output
:
Contribution to journal
›
Review article
›
peer-review
1
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antiangiogenic agents in vitreoretinal disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antiangiogenic Agents
100%
Vitreoretinal Diseases
100%
Angiogenesis
50%
Serious Complications
50%
Growth Factors
50%
Retinal Neovascularization
50%
Disease Process
50%
Laser Photocoagulation
50%
Treatment Modalities
50%
Diabetic Retinopathy
50%
Retinal Vein Occlusion
50%
Vascular Endothelial Cells
50%
Homeostatic Mechanisms
50%
Retinal Disorders
50%
Intraocular Neovascularization
50%
Diabetic Retinal
50%
Ischemic Retina
50%
Medicine and Dentistry
Proliferative Vitreoretinopathy
100%
Angiogenesis Inhibitor
100%
Disease Process
50%
Growth Factor
50%
Laser Coagulation
50%
Angiogenesis
50%
Diabetic Retinopathy
50%
Vascular Endothelial Cell
50%
Homeostasis
50%
Retina Neovascularization
50%
Retina Vein Occlusion
50%
Retinal Disease
50%
Suppressor Factor
50%
Treatment Modality
50%
Pharmacology, Toxicology and Pharmaceutical Science
Vitreoretinopathy
100%
Angiogenesis Inhibitor
100%
Growth Factor
50%
Retina Neovascularization
50%
Neovascularization (Pathology)
50%
Diabetic Retinopathy
50%
Retina Vein Occlusion
50%
Suppressor Factor
50%
Diseases
50%
Veterinary Science and Veterinary Medicine
Diseases
100%
Growth Factor
50%
Laser Coagulation
50%